Equipo médico Salvà Dr Aragon roca perfil

Dr. Juan Antonio Aragón Roca

Number of collegiate: 074705862

Qualifications and training

Degree in Medicine and Surgery from the University of Granada, 1996.
Specialist in Ophthalmology via MIR by the University Hospital of Valladolid.
D. studies in the Program “Research in Vision Sciences” of the IOBA University Institute of Applied Ophthalmobiology (University of Valladolid), 2000.
Obtaining the Suficiencia Investigadora, 2000.
Master’s Degree in Health Management, University of the Balearic Islands, 2016-2017.

Career Path

Ophthalmologist at Oftalmedic Salvà since 2009.
Specialist Surgeon in Vitreoretinal Surgery at Hospital Universitario Son Dureta/Son Espases (2002-present).
Coordinator of the Ophthalmology Service Hospital Universitario Son Espases, Palma de Mallorca (2017-2018).
Head of Ophthalmology Service Hospital Universitario Son Espases (2018-present).

Teachingactivity

Associate Professor at the Universitat de les Illes Balears (UIB), Faculty of Medicine, Ophthalmology (2018-present).
Teaching collaborator in the training of interim resident physicians in Ophthalmology (2002-2020).
Ophthalmology Resident Tutor Hospital Universitario Son Dureta (2005-2008).

Scientific activities

Researcher associated with the project: “Inhibition of experimental proliferative vitreoretinopathy (PVR) using cox-2 inhibitors” VA043/01. Junta de Castilla y León. Center: IOBA. 2000.
Collaborating investigator in “Post-authorization study to evaluate the change in the quality of vision of patients with age-related macular degeneration (AMD) treated with verteporfin photodynamic therapy (VILO Study)”. Sponsor: Novartis.
Collaborating investigator in “Open multicenter study to investigate the efficacy of macugen in the preservation of visual function in subjects with age-related macular degeneration and the benefit of treatment of choroidal neovascularization”. Sponsor: Pfizer
Principal investigator in “Phase IIIB, open-label, multicenter, 12-month, phase IIIB study to evaluate the efficacy and tolerability of ranizumab in patients with retinal edema”. Sponsor. Novartis.
Maquet JA, Dios E, Aragón J, Bailez C, Ussa F, Laguna N. Protocol for mitomycin C use in glaucoma surgery. Acta Ophthalmol Scand. 2005 Apr;83(2):196-200.
Rodriguez de la Rúa E, Pastor JC, Aragón J, Mayo-Iscar A, Martínez V, García-Arumí J, Giraldo A, Sanabria-Ruiz Colmenares MR, Miranda I. Interaction between surgical procedure for repairing retinal detachment and clinical risk factors for proliferative vitreoretinopathy. Curr Eye Res. 2005 Feb;30(2):147-53.
Olea JL, Gómez-Resa M, Cervera-Peris MM, Aragón JA. Silicone oil droplets in repackaged anti-vascular endothelial growth factors for intravitreal injections: In search of the main source of contamination. Eur J Ophthalmol. 2020;30(4):774-779. doi:10.1177/1120672118823133.
Olea JL, Sastre M, Aragón JA, Cardona A, Mateos JM. Treatment of retinal angiomatous proliferation (RAP). A retrospective study Arch Soc Esp Oftalmol. 2007 Jan;82(1):27-35.
Olea JL, Aragón JA, Zapata ME, Tur JA. [Characteristics of patients with wet age-related macular degeneration and low intake of lutein and zeaxanthin]. Arch Soc Esp Oftalmol. 2012 Apr; 87(4):112-8. doi: 10.1016/j.oftal.2011.10.007. Epub 2012 Mar 14. Spanish. PubMed PMID: 22482894.
Bibiloni Mdel M, Zapata ME, Aragón JA, Pons A, Olea JL, Tur JA. Estimation of antioxidants dietary intake in wet age-related macular degeneration patients. Nutr Hosp. 2014 Apr 1; 29(4):880-8. doi: 10.3305/nh.2014.29.4.7078. PubMed PMID: 24679031.
Escudero Bodenlle L, Olea Vallejo JL, Pons Crespi M, Aragón Roca JA, Costa Jordao C. Anti-TNF: Novelty of treatment in ocular sarcoidosis. Medicina Balear 2017; 32 (3); 47-49. doi: 10.3306/MEDICINABALEAR.32.03.47.
E Basauri, A Achurra, J Aragón, J Catalá, L Cordovés, M López, J Martínez Toldos, J Nadal, L Sararols. 2011 “Endoftamitis Infecciosa” Guías de Práctica Clínica de la SERV. ISBN 978-84-614-7906-1 DL: M-7027-2011.
E Basauri, A Achurra, J Aragón, J Catalá, L Cordovés, M López, J Martínez Toldos, J Nadal, L Sararols. 2011 “Infectious Endophthamitis” Clinical Practice Guidelines of the SERV. First revision. ISBN 978-84-606-5736-1 DL: C-132-2015.
E Basauri, J Aragón, J Catalá, L Cordovés, M López, J Martínez Toldos, A Achurra. 2011 “Infectious Endophthamitis” Clinical Practice Guidelines of the SERV. Second revision. ISBN 978-84-697-9684-9 DL: C-156-2018.
Transpupillary Thermotherapy (TTT) in progressive occult AMD. Sastre M, Aragon JA, Mateos 1M, Mulet P. Oral communication at the 81st Congress of the Spanish Society of Ophthalmology. Zaragoza, 2005.
Removal of peripapillary neovascular membrane. Urdiales A, Sastre M, Aragon JA. Oral communication at the 81st Congress of the Spanish Society of Ophthalmology. Zaragoza, 2005.
Oral communication at the 23rd National Meeting of Uveitis 2010, Spanish Society of Uveitis and Ocular Inflammation (SEDU) and Spanish Multicenter Group of Uveitis (GEMU). Valencia, 2010.
Optical coherence tomography (OCT), in vitreous retina. Dr Juan Antonio Aragón Roca. Oral communication at the I Curso de Imagen en Vitreoretina Hospital Son Espases, 2016.
Speaker at the course Initiation to Vitrectomy, Laboratorios Alcon. Barcelona, 2005, 2006, 2007, 2008.
Speaker at the 82nd Congress of the Spanish Society of Ophthalmology. Age-related macular degeneration. Significant clinical cases. Director: Dr. José Luis Olea Vallejo. 2006.
Speaker at the I Meeting on Diabetes and Obesity. Olea JL, Aragón JA. Palma de Mallorca, 2007.
JL Olea, JA Aragón, JM Mateos, P Mulet. “Uveitis due to immunorecovery”, panel communication. National Meeting of the Spanish Multicenter Uveitis Group, 2006.
JA Aragón. “Central retinal arteryobstruction in a case of AMD treated with ranibizumab”, panel communication. 84th Spanish Society of Ophthalmology Congress, 2008.
M Gomez-Resa, JL Olea, P Rocha-Cabrera, JA Aragon. “Effectiveness of infliximab in Behcet disease with previous development ofanti-infliximab antibodies”, comunicación en panel. 17th EURETINA Congress, Barcelona, 2017.
Olea JL, Aragón JA, Mateos JM, Mulet P, Gómez Resa M. “Results in clinical practice with a treat&extend regimen in wet AMD “, panel communication. XXI Congress of the Spanish Retina and Vitreous Society ( SERV), Madrid, 2017.

Other information of interest

Emili Darder Award, Real Acadèmia de Medicina de les Illes Balears: “Estudio epidemiológico de la retinopatía del prematuro de Baleares” (co-author). 2010.
Emili DarderAward, Royal Academy of Medicine of the Balearic Islands: “Characteristics of the population with low intake of luein and zeaxanthin in patients with wet AMD in the Balearic Islands” (Medicine or Surgery, Hygiene and Social Medicine category ) (co-author). 2010.